CA2697519C - Biologically active c-terminal arginine-containing peptides - Google Patents

Biologically active c-terminal arginine-containing peptides Download PDF

Info

Publication number
CA2697519C
CA2697519C CA2697519A CA2697519A CA2697519C CA 2697519 C CA2697519 C CA 2697519C CA 2697519 A CA2697519 A CA 2697519A CA 2697519 A CA2697519 A CA 2697519A CA 2697519 C CA2697519 C CA 2697519C
Authority
CA
Canada
Prior art keywords
peptide
host cell
promotion
cell
recombinant host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2697519A
Other languages
English (en)
French (fr)
Other versions
CA2697519A1 (en
Inventor
James Wilkins
Masaru Ken Shiratori
Tim Breece
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CA2697519A1 publication Critical patent/CA2697519A1/en
Application granted granted Critical
Publication of CA2697519C publication Critical patent/CA2697519C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052—Val-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA2697519A 2007-09-05 2008-09-05 Biologically active c-terminal arginine-containing peptides Active CA2697519C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96764407P 2007-09-05 2007-09-05
US60/967,644 2007-09-05
PCT/US2008/075403 WO2009033024A1 (en) 2007-09-05 2008-09-05 Biologically active c-terminal arginine-containing peptides

Publications (2)

Publication Number Publication Date
CA2697519A1 CA2697519A1 (en) 2009-03-12
CA2697519C true CA2697519C (en) 2018-11-20

Family

ID=40084302

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2697519A Active CA2697519C (en) 2007-09-05 2008-09-05 Biologically active c-terminal arginine-containing peptides

Country Status (14)

Country Link
US (5) US20090143248A1 (https=)
EP (1) EP2207790B1 (https=)
JP (1) JP5734653B2 (https=)
CN (2) CN101848925A (https=)
CA (1) CA2697519C (https=)
CY (1) CY1114618T1 (https=)
DK (1) DK2207790T3 (https=)
ES (1) ES2434829T3 (https=)
HR (1) HRP20131108T1 (https=)
PL (1) PL2207790T3 (https=)
PT (1) PT2207790E (https=)
SG (2) SG10201803541TA (https=)
SI (1) SI2207790T1 (https=)
WO (1) WO2009033024A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201803541TA (en) * 2007-09-05 2018-06-28 Genentech Inc Biologically active c-terminal arginine-containing peptides
DE102010001983A1 (de) * 2010-02-16 2011-08-18 peptides&elephants GmbH, 14558 Verfahren zur Erzeugung eines Peptidreinigungsmaterials auf Graphitbasis und Verfahren zur Peptidaufreinigung
EP2611904A2 (en) * 2010-08-31 2013-07-10 Friesland Brands B.V. Culture medium for eukaryotic cells
ES2999332T3 (en) * 2012-09-19 2025-02-25 Gemvax & Kael Co Ltd Cell penetrating peptide, conjugate comprising the same, and composition comprising conjugate
WO2017178193A1 (en) * 2016-04-14 2017-10-19 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for the identification of random polynucleotide or polypeptide sequences with biological activity
CN109575106A (zh) * 2019-01-07 2019-04-05 无限极（中国）有限公司 一种从大米多肽中制备抗氧化三肽的方法及应用
JP7166039B1 (ja) * 2020-12-22 2022-11-07 株式会社マルハチ村松 ペプチド、細胞増殖促進剤、タンパク質産生促進剤、培地、該ペプチドを用いた細胞増殖方法、及び、該ペプチドを用いたタンパク質産生方法
CN116444610B (zh) * 2022-11-30 2024-05-17 内蒙古伊利实业集团股份有限公司 乳源活性肽dasaqfir及其制备方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
EP0243469A4 (en) * 1985-10-22 1988-02-16 Plant Genetics Inc Methods and media for enhanced somatic embryogenesis.
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
AU632065B2 (en) 1988-09-23 1992-12-17 Novartis Vaccines And Diagnostics, Inc. Cell culture medium for enhanced cell growth, culture longevity and product expression
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
CA2206575A1 (en) * 1996-05-31 1997-11-30 Akzo Nobel Nv Live attenuated rtx-producing bacteria of the family pasteurellaceae
EP0810283A3 (en) 1996-05-31 1997-12-10 Akzo Nobel N.V. Live attenuated RTX-procucing bacteria of the family Pasteurellaceae
US20020045266A1 (en) * 2000-02-08 2002-04-18 Hicham Fenniri Method for determining the structure of an active member of a chemical library
US7041506B2 (en) * 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
US20040138428A1 (en) 2002-10-18 2004-07-15 Gerardo Zapata System and method for cleaving antibodies
SG10201803541TA (en) * 2007-09-05 2018-06-28 Genentech Inc Biologically active c-terminal arginine-containing peptides
EP2490021A1 (en) * 2011-02-18 2012-08-22 Biotempt B.V. Modulators of PRR and GPCR signalling

Also Published As

Publication number Publication date
US20090143248A1 (en) 2009-06-04
PT2207790E (pt) 2013-11-04
US20170088813A1 (en) 2017-03-30
EP2207790B1 (en) 2013-08-21
US20110183413A1 (en) 2011-07-28
CY1114618T1 (el) 2016-10-05
CN104844690A (zh) 2015-08-19
SG10201803541TA (en) 2018-06-28
JP2010538089A (ja) 2010-12-09
CN104844690B (zh) 2019-08-16
EP2207790A1 (en) 2010-07-21
US20170321187A1 (en) 2017-11-09
WO2009033024A1 (en) 2009-03-12
US20210163880A1 (en) 2021-06-03
DK2207790T3 (da) 2013-10-28
ES2434829T3 (es) 2013-12-17
SG190602A1 (en) 2013-06-28
CN101848925A (zh) 2010-09-29
SI2207790T1 (sl) 2013-11-29
PL2207790T3 (pl) 2014-01-31
HK1213916A1 (zh) 2016-07-15
CA2697519A1 (en) 2009-03-12
JP5734653B2 (ja) 2015-06-17
HRP20131108T1 (hr) 2014-01-31

Similar Documents

Publication Publication Date Title
US20210163880A1 (en) Biologically active c-terminal arginine-containing peptides
Kubota et al. Proteome analysis of secreted proteins during osteoclast differentiation using two different methods: two‐dimensional electrophoresis and isotope‐coded affinity tags analysis with two‐dimensional chromatography
Thingholm et al. Analytical strategies for phosphoproteomics
Toepert et al. Combining SPOT synthesis and native peptide ligation to create large arrays of WW protein domains
Wierling et al. High‐throughput screening of packed‐bed chromatography coupled with SELDI‐TOF MS analysis: monoclonal antibodies versus host cell protein
CA2504413A1 (en) Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore
CN103097516A (zh) 真核细胞培养基
CN114651065A (zh) 导入用于提高蛋白质生产性的单个条形码系统的信号肽超高速筛选方法
Krause et al. Sequence diversity of the peptaibol antibiotic suzukacillin‐A from the mold Trichoderma viride
Ruse et al. Polyglutamylation: biology and analysis
Tan et al. Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells
WO1997043301A2 (en) Identification of members of combinatorial libraries by mass spectrometry
Zhang et al. A proteomics approach to study in vivo protein Nα-modifications
HK1213916B (zh) 有生物學活性的、含c-端精氨酸的肽
Mosser et al. Chromatographic fractionation of yeast extract: a strategy to identify physicochemical properties of compounds promoting CHO cell culture
Intoh et al. Separation with zwitterionic hydrophilic interaction liquid chromatography improves protein identification by matrix‐assisted laser desorption/ionization‐based proteomic analysis
Wu et al. Purification of angiotensin I-converting enzyme (ACE) inhibitory peptides from casein hydrolysate by IMAC-Ni2+
Villar et al. Systematic characterization of phosphorylation sites in NFATc2 by linear ion trap mass spectrometry
US20160033527A1 (en) System and method for determining amino acid sequence of polypeptide
Nemoto Applications of the wheat germ cell-free protein synthesis system in plant biochemical studies
Schwartz et al. Peptide Mapping of a Wheat Gluten Hydrolysate by Reversed-Phase High Performance Liquid Chromatography (RP-HPLC)
Kawakami et al. Microidentification of N-terminal-blocked amino acid residues of proteins and peptides
Kasama et al. A high throughput sequence determination for one cyclic peptide immobilized on a single bead by MALDI-TOF-MS/MS focusing on discovery of interacting peptides and medicinal medium sized molecules
Schwartz et al. Quality control of a wheat gluten hydrolysate for use as a raw material in cell culture media
Cho et al. Quantitative phosphoproteomics of the human neural stem cell differentiation into oligodendrocyte by mass spectrometry

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130828

H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20250305